As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Bio-Techne TECH reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of 53 cents, which surpassed the Zacks Consensus Estimate by 6%. The bottom line improved from the year-ago figure ...

--Bio-Techne Corporation today reported its financial results for the first quarter ended September 30, 2025. "The Bio-Techne team once again executed with focus and agility in a dynamic operating ...

Bio-Techne TECH continues to expand its portfolio and enter adjacent markets via acquisitions and strategic investments. Strength in international markets underscores the company’s growth potential.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-releases-fourth-quarter-fiscal-2025-results-302522577.html ...